Raghu Ram Chivukula, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucociliary Clearance | 1 | 2020 | 67 | 0.710 |
Why?
|
| MicroRNAs | 12 | 2023 | 3752 | 0.710 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2021 | 437 | 0.620 |
Why?
|
| Critical Care | 1 | 2020 | 2647 | 0.310 |
Why?
|
| Critical Illness | 1 | 2020 | 2670 | 0.310 |
Why?
|
| Biomedical Research | 1 | 2022 | 3309 | 0.280 |
Why?
|
| Acute Lung Injury | 2 | 2018 | 380 | 0.240 |
Why?
|
| Physicians | 1 | 2022 | 4567 | 0.230 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 3036 | 0.230 |
Why?
|
| Internship and Residency | 1 | 2022 | 5788 | 0.200 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1294 | 0.200 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2022 | 162 | 0.200 |
Why?
|
| Drug Compounding | 1 | 2022 | 242 | 0.190 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2020 | 115 | 0.180 |
Why?
|
| Ciliary Motility Disorders | 1 | 2020 | 47 | 0.180 |
Why?
|
| Cell Cycle | 1 | 2008 | 2967 | 0.180 |
Why?
|
| Microscopy, Video | 1 | 2020 | 245 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 780 | 0.160 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2020 | 214 | 0.160 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 428 | 0.150 |
Why?
|
| Regeneration | 2 | 2018 | 1485 | 0.150 |
Why?
|
| Respiratory System | 1 | 2020 | 557 | 0.140 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 459 | 0.140 |
Why?
|
| Cilia | 1 | 2020 | 466 | 0.140 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 500 | 0.140 |
Why?
|
| Career Choice | 1 | 2022 | 744 | 0.130 |
Why?
|
| Schools, Medical | 1 | 2022 | 880 | 0.130 |
Why?
|
| Homozygote | 1 | 2020 | 1785 | 0.130 |
Why?
|
| Pulmonary Alveoli | 1 | 2018 | 675 | 0.130 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2014 | 27 | 0.120 |
Why?
|
| Cell Separation | 1 | 2020 | 1751 | 0.120 |
Why?
|
| Somatomedins | 1 | 2014 | 192 | 0.120 |
Why?
|
| Dextran Sulfate | 1 | 2014 | 236 | 0.120 |
Why?
|
| Pulmonary Fibrosis | 1 | 2018 | 530 | 0.120 |
Why?
|
| Paracrine Communication | 1 | 2014 | 277 | 0.110 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 1177 | 0.110 |
Why?
|
| Lung Transplantation | 2 | 2018 | 1153 | 0.110 |
Why?
|
| Myofibroblasts | 1 | 2014 | 222 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2010 | 3002 | 0.110 |
Why?
|
| Dependovirus | 2 | 2015 | 706 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2014 | 319 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1199 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2009 | 11483 | 0.100 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2012 | 191 | 0.100 |
Why?
|
| Isotachophoresis | 1 | 2010 | 1 | 0.100 |
Why?
|
| Epithelial Cells | 2 | 2021 | 3690 | 0.100 |
Why?
|
| Sinusitis | 1 | 2020 | 923 | 0.100 |
Why?
|
| Mesoderm | 1 | 2014 | 686 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2022 | 1905 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4204 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2018 | 1354 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1799 | 0.090 |
Why?
|
| Cyclins | 2 | 2009 | 603 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2020 | 1479 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2020 | 5974 | 0.080 |
Why?
|
| Hepatocytes | 1 | 2015 | 1211 | 0.080 |
Why?
|
| Pneumonia | 1 | 2020 | 2133 | 0.080 |
Why?
|
| Blood Group Incompatibility | 1 | 2008 | 146 | 0.080 |
Why?
|
| Genetic Vectors | 2 | 2015 | 3420 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2009 | 987 | 0.070 |
Why?
|
| ABO Blood-Group System | 1 | 2008 | 367 | 0.070 |
Why?
|
| Mice | 10 | 2023 | 81183 | 0.070 |
Why?
|
| Phenotype | 2 | 2020 | 16365 | 0.070 |
Why?
|
| ras Proteins | 1 | 2010 | 1060 | 0.060 |
Why?
|
| Animals | 12 | 2023 | 168757 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 1863 | 0.060 |
Why?
|
| Distance Perception | 1 | 2004 | 19 | 0.060 |
Why?
|
| Humans | 21 | 2022 | 744343 | 0.060 |
Why?
|
| Illusions | 1 | 2004 | 60 | 0.060 |
Why?
|
| Adenoma | 1 | 2014 | 2174 | 0.060 |
Why?
|
| Growth and Development | 1 | 2023 | 52 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 5256 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1783 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2009 | 1538 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 2541 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 9856 | 0.050 |
Why?
|
| Transplantation Conditioning | 1 | 2008 | 1598 | 0.050 |
Why?
|
| Gene Expression | 3 | 2022 | 7799 | 0.050 |
Why?
|
| Space Perception | 1 | 2004 | 475 | 0.050 |
Why?
|
| Cell Division | 1 | 2008 | 4568 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2012 | 2214 | 0.050 |
Why?
|
| Adult | 7 | 2020 | 214055 | 0.050 |
Why?
|
| Microtubule Proteins | 1 | 2020 | 61 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 1903 | 0.040 |
Why?
|
| Saudi Arabia | 1 | 2020 | 209 | 0.040 |
Why?
|
| Nanomedicine | 1 | 2022 | 304 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 13695 | 0.040 |
Why?
|
| Liposomes | 1 | 2022 | 759 | 0.040 |
Why?
|
| Mutation | 2 | 2020 | 29786 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.040 |
Why?
|
| Consanguinity | 1 | 2020 | 454 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 2008 | 1194 | 0.040 |
Why?
|
| Neoplasms | 2 | 2022 | 21683 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1143 | 0.040 |
Why?
|
| Transcription Factors | 3 | 2020 | 12208 | 0.040 |
Why?
|
| Liver Neoplasms | 2 | 2012 | 4253 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2023 | 1701 | 0.040 |
Why?
|
| Walking | 1 | 2004 | 1180 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 427 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.040 |
Why?
|
| Epithelium | 1 | 2021 | 1679 | 0.040 |
Why?
|
| Time | 1 | 2018 | 542 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 1901 | 0.030 |
Why?
|
| Autoantigens | 1 | 2020 | 892 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2015 | 64 | 0.030 |
Why?
|
| Myocardium | 1 | 2008 | 4776 | 0.030 |
Why?
|
| Genome | 1 | 2023 | 1808 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 16689 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2015 | 109 | 0.030 |
Why?
|
| United States | 1 | 2022 | 69872 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 56430 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2008 | 4251 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 85781 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 4644 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2014 | 10481 | 0.030 |
Why?
|
| Apoptosis | 1 | 2008 | 9727 | 0.030 |
Why?
|
| Child | 1 | 2020 | 77709 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 386 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 8428 | 0.020 |
Why?
|
| Female | 7 | 2020 | 380194 | 0.020 |
Why?
|
| Genes, myc | 1 | 2012 | 399 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 1861 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 513 | 0.020 |
Why?
|
| Electrolytes | 1 | 2010 | 282 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 769 | 0.020 |
Why?
|
| Cyclin D2 | 1 | 2009 | 101 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2020 | 3023 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 9648 | 0.020 |
Why?
|
| Cell Line | 2 | 2015 | 15997 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 2008 | 211 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2008 | 199 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1097 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 1741 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 2007 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 6314 | 0.020 |
Why?
|
| Genomics | 1 | 2022 | 5720 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 727 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 1224 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 5853 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 3689 | 0.020 |
Why?
|
| Heart Failure | 1 | 2008 | 10900 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2010 | 1005 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2008 | 652 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2009 | 1730 | 0.010 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2010 | 828 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1889 | 0.010 |
Why?
|
| Head Movements | 1 | 2004 | 150 | 0.010 |
Why?
|
| Polymers | 1 | 2010 | 1621 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2010 | 1692 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3557 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2596 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5217 | 0.010 |
Why?
|
| Male | 6 | 2020 | 350118 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5882 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 9734 | 0.010 |
Why?
|
| Fibrosis | 1 | 2008 | 2029 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 18029 | 0.010 |
Why?
|
| Lipids | 1 | 2012 | 3305 | 0.010 |
Why?
|
| Base Sequence | 1 | 2012 | 12797 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2008 | 1224 | 0.010 |
Why?
|
| RNA | 1 | 2010 | 2749 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 4776 | 0.010 |
Why?
|
| Neutrophils | 1 | 2012 | 3719 | 0.010 |
Why?
|
| Zebrafish | 1 | 2010 | 2994 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4554 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2008 | 4199 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2004 | 2025 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6538 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 7322 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 63114 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14557 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 12072 | 0.010 |
Why?
|
| Liver | 1 | 2012 | 7474 | 0.010 |
Why?
|
| Biopsy | 1 | 2008 | 6756 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2008 | 3821 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2008 | 4397 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2008 | 3110 | 0.010 |
Why?
|
| Linear Models | 1 | 2004 | 5952 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 10397 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 23338 | 0.000 |
Why?
|
| Time Factors | 1 | 2008 | 40075 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2008 | 77449 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 163280 | 0.000 |
Why?
|
| Middle Aged | 1 | 2008 | 213383 | 0.000 |
Why?
|